57 / 87
LISI MEDICAL
A
dvances in medicine and sociodemogr aphic
developments (aging, obesity, development of emerging
countries), open up new fields of application for
LISI MEDICAL products. Minimally invasive surgery
instruments, which bring about a number of innovations, are
indeed increasingly used in general, visceral, neurological and
urological surgery, and also more recently in orthopedics,
a segment where LISI MEDICAL is historically positioned.
Surgical Robots and 3D Printing
The emergence of surgical robots, a new development factor
in minimally invasive surgery, is revolutionizing sectors that
have so far been relatively weak. All the major players in
orthopedics are now equipped. The orthopedics market has
seen its growth (+4%) partly driven by the increasing adoption
of robots in the treatment of diseases of the hip, knee and
spine, and by the development of minimally invasive
instrumentation for spine or trauma surgery. These positive
developments are complemented by the development of
additive manufacturing techniques (3D printing), which
transforms the traditional industrial approach, particularly in
the dental, maxillofacial and, more recently, orthopedic sectors.
Concentration and race for innovation
The movement towards concentration that has prevailed for
several years in the medical device sector continued in 2017.
Tariff pressures exerted on the industry to accompany the
general reduction of health expenditures indeed encourage
industry players to seek the critical size, to intensify their
innovation efforts in order to value and/or differentiate their
offer. This movement is still under way and is reflected in
outsourcing. In order to reduce their costs, themain customers
have today a tendency to reduce the number of their
subcontractors, to keep only those whose industrial capacity
is significant, international and sustainable. The consolidation
of LISI MEDICAL Remmele, acquired in 2016, now enables the
division to offer this profile to its customers.
A WORLD PLAYER
EUR
137
million
2017 sales revenue
EUR
9.8
million
EBIT (+ 5.7%)
+4
%
Growth of the orthopedic market
53
MARKETS & PRODUCTS